Skip to content
Search

Latest Stories

Vaping remains popular aid to quit smoking: PHE

More smokers need support to switch to vape but nearly one in six smokers incorrectly believe vaping to be more harmful than combustible tobacco, Public Health England has revealed.

The findings come from the seventh annual independent report summarising the evidence on vape products, commissioned by Public Health England (PHE).


Evidence on adult use of vape products came from four surveys, predominantly sourced from the ASH-ADULT survey and STS (Smoking Toolkit Survey) data. It shows a continued clear decline in smoking rates in England, now standing between 13.8 per cent and 16 per cent, depending on the methodology used.

The report shows that last year 27.2 per cent of people had used a vape product in a recent quit attempt, making it by far the most popular quitting aid. However, only 11 per cent of local authorities offer vape products as part of their approach to helping smokers quit.

The PHE report states: “As suggested in previous evidence reviews, combining vaping products (the most popular source of support used by people making a quit attempt in the general population), with stop smoking service support (the most effective type of support), should be an option available to all people who want to quit smoking.”

The report highlights variation in vaping prevalence by socio-demographic groups and smoking status. Using STS data, 7.2 per cent of men, 7.7 per cent of people in the north of England and 7.6 per cent of people from social grades C2, D and E vaped.

Vaping prevalence was between 17.5 per cent and 20.1 per cent among current smokers, around 11 per cent among former smokers and between 0.3 per cent and 0.6 per cent among never smokers. Around 10 per cent of long-term former smokers (quit for longer than 1 year) vaped, compared with 24 per cent of short-term former smokers (quit for less than one year).

Encouragingly, the proportion of vapers who also smoke has declined since 2012, from 74 per cent to 38 per cent in the ASH-Adult and from 92 per cent to 51 per cent in the STS survey. The PHE report’s authors state that the discrepancy is likely due to different definitions of smoking status.

More positive news highlights how vaping is becoming an established long-term route out of smoking for many. The proportion of current vapers who have vaped for more than three years appears to be increasing (23.7 per cent in 2018, 29.3 per cent in 2019, 39.2 per cent in 2020).

The proportion of new current vapers who have vaped for less than one month in 2020 was 2.6 per cent (5.5 per cent in 2018, 5.1 per cent in 2019). People who had vaped in the past mostly stopped after six months of use or less (59.9 per cent in 2020).

Yet a major challenge that continues to hold back the industry is the misconceptions that many smokers have about the relative risks of vaping.

The STS survey found that only 29 per cent of current smokers believed vaping was less harmful than smoking, with 38 per cent believed vaping was as harmful as smoking, 18 percent unsure and 15 per cent believing vaping to be more harmful than smoking. Misperceptions were more pronounced among smokers from social grades C2, D and E.

The PHE report also collected data emphasising the embryonic nature of some competitor next generation nicotine products. Use of heated tobacco products by adults in England was estimated at 0.3 per cent and use of nicotine pouches at 0.5 per cent in 2020.

Evidence on youth vaping collated in the report shows that there has been little change in the prevalence of vaping or smoking among young people in the past five years, despite fears from some campaigners that vaping could become a backdoor to increasing youth smoking rates.

More For You

AAH Pharmaceuticals introduces 20 new electric vans to its delivery fleet

18 vans have been added to the AAH DC in Ruislip, and another 2 to their branch in Glasgow

Photo credit: AAH

AAH Pharmaceuticals adds 20 new electric vans to reduce carbon emissions

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced 20 new electric vans to its delivery fleet, marking a significant step forward in its Carbon Reduction Plan, which is aligned to the NHS net zero targets.

Eighteen of the new electric vehicles have been deployed at the AAH distribution centre in Ruislip, with the remaining two now in operation at its Glasgow branch.

Keep ReadingShow less
Numark launches new digital consultation platform to support independent prescribers

Harry McQuillan, Chairman of Numark

Numark launches DigiPharma to empower independent prescribers

Numark has launched a new digital consultation platform, called DigiPharma, designed to support both current and future independent prescribers (IPs) in making full use of their qualifications.

The revolutionary cloud-based prescribing recording platform is now available exclusively to Numark members.

Keep ReadingShow less
Operation Subaru:

Some of the medicines seized in raids today. Credit: MHRA

12 arrested in MHRA’s biggest medicines trafficking crackdown

Twelve people have been arrested in a series of dawn raids across the West Midlands and the Northwest of England today (29 April), as part of the biggest criminal investigation ever undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA) into organised medicines trafficking.

The suspects were detained on suspicion of involvement in organised crime, conspiracy to sell or supply controlled and unlicensed medicines, and money laundering.

Keep ReadingShow less
Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less